Evaluation of immune response following one dose of an AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in Japanese adults 65 years of age or older

Objective: This study assessed the immunogenicity, long-term persistence of immune response and safety of a single dose of an A/California/07/2009 H1N1 pandemic influenza vaccine adjuvanted with AS03 (α-tocopherol and squalene based oil-in-water emulsion Adjuvant System) in subjects ≥ 65 y of age (N...

Full description

Bibliographic Details
Main Authors: Hideyuki Ikematsu, Kazuyoshi Tenjinbaru, Ping Li, Anuradha Madan, David Vaughn
Format: Article
Language:English
Published: Taylor & Francis Group 2012-08-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:https://www.tandfonline.com/doi/10.4161/hv.21081